TTRX earnings date and last-quarter result: next report 2026-08-10, last quarter miss, P/E -52.94. Updated 2026-07-23.
Turn Therapeutics (TTRX) Research Hub
Turn Therapeutics (TTRX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 10.61 USD (+3.21%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -52.94, market cap 0.30B. This hub links to the full technical, earnings and options research available for TTRX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 10.61 USD (+3.21%) |
| 52-week range | 5.55 USD – 16.45 USD |
| Trend regime | Range |
| 14-day RSI | 42 (Bearish) |
| Trailing P/E | -52.94 |
| Market cap | 0.30B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for TTRX
Covered Call on TTRX: how it works, illustrative setup around the real 10.61 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TTRX: how it works, illustrative setup around the real 10.61 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TTRX: how it works, illustrative setup around the real 10.61 USD price, max profit/loss, breakeven and when to use it. Educational.
TTRX technical analysis: range, last 10.61 USD, RSI 42, 52w range 5.55 USD–16.45 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is TTRX in?
Turn Therapeutics (TTRX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TTRX in an uptrend or downtrend?
As of 2026-10-26, TTRX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TTRX's trailing P/E ratio?
TTRX's trailing P/E is -52.94, with a market cap of 0.30B. See the earnings research page for full valuation detail.
When does TTRX next report earnings?
TTRX is next scheduled to report earnings on 2026-08-10.